The Wolverine

BPC-157 + TB-500 BPC-157 and TB-500 is an experimental peptide blend used in laboratory research involving cellular repair and tissue-response pathways. BPC-157 is a synthetic 15-amino-acid peptide investigated primarily in preclinical models involving gastrointestinal tissue, tendons, ligaments, muscles, bone, inflammation, nitric-oxide signaling, and blood-vessel formation. TB-500 is generally identified as a seven-amino-acid fragment of thymosin beta-4. It is studied in relation to actin regulation, cellular migration, angiogenesis, inflammation, and tissue-remodeling pathways. TB-500 is not equivalent to full-length thymosin beta-4, and results involving the full-length molecule cannot automatically be attributed to TB-500. This combination is sometimes called the “Wolverine blend.” However, reliable controlled human studies have not established the safety, effectiveness, interactions, or long-term effects of combining BPC-157 and TB-500. Neither compound is an FDA-approved medication or treatment. Research Use Only: This product is intended strictly for laboratory research and analytical purposes. It is not approved for human or veterinary use, consumption, diagnosis, treatment, or administration.